Leukotriene B 4 (LTB 4 ) receptor type 1 (BLT1) is abundant in phagocytic and immune cells and plays crucial roles in various inflammatory diseases. BLT1 is phosphorylated at several serine and threonine residues upon stimulation with the inflammatory lipid LTB 4 . Using Phos-tag gel electrophoresis to separate differentially phosphorylated forms of BLT1, we identified two distinct types of phosphorylation, basal and ligand-induced, in the carboxyl terminus of human BLT1. In the absence of LTB 4 , the basal phosphorylation sites were modified to various degrees, giving rise to many different phosphorylated forms of BLT1. Different concentrations of LTB 4 induced distinct phosphorylation events, and these ligand-induced modifications facilitated additional phosphorylation events at the basal phosphorylation sites. Because neutrophils migrate toward inflammatory sites along a gradient of LTB 4 , the degree of BLT1 phosphorylation likely increases in parallel with the increase in LTB 4 concentration as the cells migrate. At high concentrations of LTB 4 , deficiencies in these two types of phosphorylation events impaired chemotaxis and b-hexosaminidase release, a proxy for degranulation, in Chinese hamster ovary (CHO-K1) and rat basophilic leukemia (RBL-2H3) cells, respectively. These results suggest that an LTB 4 gradient around inflammatory sites enhances BLT1 phosphorylation in a stepwise manner to facilitate the precise migration of phagocytic and immune cells and the initiation of local responses, including degranulation.
INTRODUCTION
With more than 900 members, G protein-coupled receptors (GPCRs) are the largest family of cellular receptors (1) . Binding of an agonist to a GPCR induces a conformational change in the receptor, which stimulates dissociation of the heterotrimeric G proteins associated with the receptor. The dissociated Ga and Gbg subunits stimulate diverse cellular responses through effector proteins and intracellular second messengers (2) . When the activated receptors are phosphorylated on Ser and Thr residues within the intracellular loops and the carboxyl tail, cellular responses to subsequent stimuli are usually attenuated, a phenomenon known as desensitization. The functional significance of GPCR phosphorylation has also been characterized in contexts other than desensitization. For example, the distinct GPCR phosphorylation profiles mediated by different kinases (the phospho-barcodes) explain the multidimensional features of GPCR signaling networks (3) (4) (5) (6) . Thus, precise analysis of the phosphorylation of specific GPCRs is useful for clarifying the biological functions of each receptor.
Leukotriene B 4 (LTB 4 ) is a lipid mediator that is derived from arachidonic acid in the plasma membrane and released into the extracellular milieu (7) (8) (9) , where it acts as a potent chemoattractant for neutrophils and lymphocytes (10) . Experiments using microscale arrays have demonstrated that the LTB 4 chemotactic gradient is important for triggering neutrophil swarming (11, 12) . The LTB 4 receptor type 1 (BLT1) is a high-affinity LTB 4 receptor that is abundant in and contributes to the activation and migration of phagocytic and immune cells, such as neutrophils, eosinophils, dendritic cells, macrophages, B cells, and T cells (13) . BLT1 is a GPCR and activates at least two different Ga family members, including the pertussis toxin (PTX)-sensitive G i/o and PTX-insensitive G q alpha proteins (14, 15) . The activation of these Ga proteins by BLT1 results in phosphoinositide hydrolysis, intracellular Ca 2+ mobilization, and a decrease in cellular cyclic adenosine monophosphate, followed by chemotaxis and degranulation (15, 16) . Like other GPCRs, BLT1 is phosphorylated in its C-terminal tail after activation. Several studies have reported the phosphorylation of BLT1 (17) (18) (19) , yet the precise phosphorylation sites and their biological importance remain to be determined.
Here, we determined the amino acid residues responsible for basal (constitutive) and ligand-induced phosphorylation of human BLT1 using Phos-tag SDS-polyacrylamide gel electrophoresis (PAGE), in which a small molecule that is incorporated into the polyacrylamide gel matrix slows the mobility of phosphorylated proteins by specifically binding to phosphate groups. Subsequent mutational analyses established the phosphorylation hierarchies of these residues. To better understand the biological roles of these phosphorylation events, we examined chemotaxis and b-hexosaminidase release elicited by different concentrations of LTB 4 using BLT1 mutants lacking the identified phosphorylation sites. We found that an LTB 4 gradient boosted BLT1 phosphorylation in a stepwise manner to facilitate the precise migration of immune cells and the initiation of local responses, including degranulation.
RESULTS
BLT1 is phosphorylated basally and LTB 4 inducibly Because BLT1 on the cell surface is covalently modified with N-glycan moieties of various molecular masses, wild-type human BLT1 that is N-terminally tagged with hemagglutinin (HA-BLT1/WT) and expressed in HeLa cells appears as diffuse bands by SDS-PAGE ( fig. S1A ), making it difficult to detect the phosphorylation of BLT1 as a band shift in Western blot analysis. To eliminate this problem, we generated a BLT1 mutant in which the two putative N-glycosylation sites in the extracellular domain, Asn 2 and Asn
164
, were mutated to Ala. The resulting protein, HA-BLT1/0N, is a prospective N-glycosylation-deficient receptor. When expressed in HeLa cells, HA-BLT1/0N appeared as a sharp band on the SDS-PAGE ( fig. S1A ), although the band migrated slightly more slowly than that of endoglycosidase-treated HA-BLT1/ WT (fig. S1A). This difference could be due to posttranslational modifications other than N-glycosylation. The trafficking of HA-BLT1/0N to the cell surface was identical to that of HA-BLT1/WT (fig. S1B). Furthermore, HA-BLT1/0N showed LTB 4 -elicited intracellular Ca 2+ mobilization, although this activity was slightly lower than that of HA-BLT1/WT (fig. S1C). These results indicate that HA-BLT1/0N is a useful tool for the analysis of BLT1 phosphorylation sites.
We performed Western blot analysis of HA-BLT1/0N expressed in HeLa cells with or without LTB 4 stimulation. Although LTB 4 stimulation led to the appearance of a shifted band on the polyacrylamide gel, the separation of phosphorylated and nonphosphorylated HA-BLT1/0N was not sufficient for precise analysis (Fig. 1A) . Therefore, we used Phos-tag technology with SDS-PAGE, which allows for the specific separation of various phosphorylated forms of proteins (20) . HA-BLT1/0N migrated as multiple bands on the Phos-tag SDS-PAGE without LTB 4 stimulation (Fig. 1A) , suggesting that various LTB 4 independent phosphorylations occur at multiple sites. Moreover, additional slower migrating bands appeared after LTB 4 stimulation. These shifted bands disappeared with alkaline phosphatase (AP) treatment (Fig. 1B) , demonstrating that these shifted bands were due to the phosphorylation of HA-BLT1/0N. We also examined the phosphorylation states of HA-BLT1/WT from LTB 4 -treated cells after treatment with endoglycosidase by Phos-tag SDS-PAGE. There was no substantial difference in the band patterns between endoglycosidasetreated HA-BLT1/WT and HA-BLT1/0N (Fig. 1C) , suggesting that N-glycosylation has no effect on these LTB 4 -induced modifications. Moreover, BLT1 endogenously expressed in retinoic acid-stimulated human promyelocytic leukemia (HL-60) cells shared a phosphorylation pattern similar to that of exogenously expressed HA-BLT1/WT (Fig. 1D) . Together, these data demonstrate that BLT1 was phosphorylated to various extents even in the resting state (henceforth referred to as "basal phosphorylation") and that LTB 4 stimulation induced additional phosphorylation events (henceforth referred to as "LTB 4 -induced phosphorylation").
BLT1 has seven phosphorylated residues in its C terminus GPCR phosphorylation occurs on Ser and Thr residues in the cytoplasmic domains (21) . There are 21 Ser and Thr residues that are conserved among the cytoplasmic domains of human, mouse, rat, guinea pig, and zebrafish BLT1s ( fig. S2 ). Because kinases require specific motifs around the target residue, we excluded Ser 343 and Ser 344 from our analysis because of the low homology surrounding these residues among different species. To identify the amino acid residues critical for basal phosphorylation of BLT1, we divided the remaining 19 residues into 10 subgroups based on the proximity of the residues and generated 10 mutant HA-BLT1/0N receptors in which these residues were replaced with Ala ( Fig. 2A) . The Phos-tag SDS-PAGE analyses revealed that Ser and Thr residues in the intracellular loops were not part of the basal phosphorylation profile; however, the iL-1 mutant (S51A and T53A) was not produced in HeLa cells, as previously reported ( Fig. 2B) (22) . The bands for mutants iL-2B (S125A and T130A) and iL-3B (S216A and T219A) showed a slight difference in mobility compared to HA-BLT1/0N (Fig. 2B) , possibly because we used a twofold greater volume of the mutant samples relative to HA-BLT1/0N to generate comparable signal intensity. On the other hand, the mutant forms of HA-BLT/0N bearing substitution mutations in the C terminus, CT-3 (S313A, S314A, and T315A) and CT-4 (S320A and T324A), displayed aberrant basally phosphorylated bands after Phos-tag SDS-PAGE (Fig. 2B) . Next, we examined the amino acid residues involved in LTB 4 -induced phosphorylation. Previous reports demonstrated that the substitution of all Ser and Thr residues in the C-terminal domain with Ala led to a notable disappearance of LTB 4 -induced phosphorylation, suggesting that the phosphorylation of these sites depends on LTB 4 (17) . Thus, we focused our mutational analyses on Ser and Thr residues in the C-terminal domain. Mutant receptor CT-2 (T308A and S310A) did not show any band shifts upon LTB 4 treatment (Fig. 2C) 4 induced phosphorylation sites, we generated 12 additional mutants in which these residues were mutated individually and in various combinations (Fig. 2D) , mutated to Ala. To determine whether all or only a subset of these residues was basally phosphorylated, we constructed five mutants in which only one of these five residues was not substituted with Ala (BLT1/0N/ S313, BLT1/0N/S314, BLT1/0N/T315, BLT1/0N/S320, and BLT1/ 0N/T324). Each of these five mutants migrated more slowly, and substitution of all five residues (BLT1/0NDb-phos) led to the complete disappearance of shifted bands in the absence of LTB 4 (Fig. 2, C ), we generated mutants in which only one of these two residues was mutated (BLT1/0N/T308 and BLT1/0N/S310, respectively) and mutants in which one of these two residues was mutated in addition to the five basally phosphorylated residues (Db/T308 and Db/S310, respectively). Each of these mutants still exhibited the LTB 4 -induced shifts, indicating that both residues were involved in LTB 4 -induced phosphorylation (Fig. 2F) . Moreover, the BLT1/0NDb-phos mutant, completely devoid of basal phosphorylation, displayed LTB 4 -stimulated band shifts (Fig. 2F) , demonstrating that basal phosphorylation was not required for LTB 4 -induced phosphorylation.
We next compared three mutant receptors in which all five of the residues that were basally phosphorylated were mutated (HA-BLT1/ 0NDb-phos), both of the residues that exhibited LTB 4 -induced phosphorylation were mutated (HA-BLT1/0NDi-phos), or all seven residues E F A iL-1 : S51A, T53A  iL-2A : S116A  iL-2B : S125A, T130A  iL-3A : S200A, S202A  iL-3B : S216A, T219A  CT-1 : S295A  CT-2 : T308A, S310A  CT-3 : S313A, S314A, T315A  CT-4 : S320A, T324A  CT-5 : S337A, were mutated (HA-BLT1/0NDphos) (Fig. 2D) . HA-BLT1/0NDb-phos and HA-BLT1/0NDi-phos exhibited greatly reduced basal phosphorylation and LTB 4 ) in its C-terminal region. The presence of many distinctly migrating bands for the wild-type protein and each mutant form indicates that phosphorylation of these residues may occur in many different combinations.
Phosphorylation of BLT1 is facilitated by dose-dependent LTB 4 stimulation To evaluate whether different concentrations of LTB 4 affected the extent of human BLT1 phosphorylation, we stimulated HeLa cells expressing HA-BLT1/0N or HA-BLT1/0NDb-phos with various concentrations of LTB 4 . The LTB 4 -induced phosphorylation of both HA-BLT1/0N and HA-BLT1/0NDb-phos increased in a dosedependent manner (Fig. 3, A and B) . For the HA-BLT1/0NDb-phos mutant, one of the LTB 4 -induced phosphorylated species initially appeared at 1 nM LTB 4 , but the other LTB 4 -induced phosphorylated species (phosphorylated on both Ser 310 and Thr
308
) only appeared in LTB 4 concentrations at or above 30 nM (Fig. 3A) . On the basis of the position of the band, the faster-migrating phosphorylated species appearing at 1 nM LTB 4 likely corresponded to phosphorylation on Ser 310 (Fig. 2F) , and the slower migrating band likely corresponded to phosphorylation on both Ser 310 and Thr
. These results raise the possibility that each residue that is phosphorylated in an LTB 4 dependent manner can act as a sensor for different LTB 4 concentrations. Moreover, the total phosphorylation of BLT1/0N was initially enhanced by 1 nM LTB 4 , followed by a gradual increase, with the maximal phosphorylation observed at concentrations more than 30 nM (Fig. 3B) . These data further suggest that the phosphorylation of each LTB 4 -induced phosphorylation site could trigger additional phosphorylation events at the sites initially identified as basal phosphorylation sites.
Stepwise addition of LTB 4 enhances BLT1 phosphorylation The cell responses to activation of BLT1, such as an increase in intracellular [Ca 2+ ], are immediately shut down after the initial stimulation of LTB 4 (23 (Fig. 4A) . Exposing cells to 100 nM LTB 4 after stimulation with 10 nM LTB 4 increased the extent to which BLT1/0N was phosphorylated compared to stimulation with 10 nM LTB 4 alone (Fig. 4B ) and did not stimulate additional activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) after the cells were desensitized by the primary stimulation (Fig. 4B) . Similar results were obtained in CHO-K1, Ba/F3, and RBL-2H3 cells (Fig. 4C) . In HeLa cells expressing BLT1/0N, the additional phosphorylation in response to 100 nM LTB 4 treatment after prestimulation was greatly diminished by cotreatment with an equal amount of BLT1 antagonist, CP105696 or ZK158252 (Fig. 4 , D and E) (24) . Previously, Okuno et al. found that the conformation of human BLT1 switches from a high-affinity state to a low-affinity state after activation of the downstream G proteins (25) . These results raise the possibility that a low-affinity form of BLT1 remains on the cell surface after ligand stimulation and could be modified by additional phosphorylation events upon exposure to higher LTB 4 concentrations. To investigate the existence of BLT1 on the cell surface after stimulation with 10 nM LTB 4 , we fluorescently labeled BLT1 using sortase A (SrtA)-mediated transpeptidation, known as sortagging (26, 27) , and examined the trafficking of the labeled BLT1 after stimulation with LTB 4 . It has been reported that only a portion (~30%) of BLT1 undergoes internalizations after stimulation with LTB 4 (17, 19, 28, 29) . In keeping with these findings, a substantial amount of both the labeled BLT1/0N and BLT1/ 0NDphos remained on the surface of Ba/F3 cells at least 20 min after stimulation with 10 nM LTB 4 , with only~5% detected in the intracellular vesicles. These data suggest that BLT1 remains on the cell surface after ligand stimulation and thus could be modified by additional phosphorylation events upon exposure to higher LTB 4 concentrations (Fig. 4 , F and G). 
LTB 4 -induced phosphorylation facilitates the degree of BLT1 basal phosphorylation
We investigated whether LTB 4 -induced phosphorylation affected the degree to which basal phosphorylation sites were modified during the stepwise addition of LTB 4 in HeLa cells. After primary (10 nM) and stepwise (100 nM) additions of LTB 4 , a larger proportion of BLT1/0N was highly phosphorylated compared to nonphosphorylated BLT1/0N (Fig. 5 , A and B). In contrast, the highly phosphorylated forms of BLT1/Di-phos were substantially reduced, and the nonphosphorylated forms were increased, compared to BLT1/0N, even after stimulation with 100 nM LTB 4 ( Fig. 5 , A and B). Because the total phosphorylation of BLT1 increased in parallel with the modification of each LTB 4 -induced phoshorylation site (Fig. 3) , the reduction in highly phosphorylated forms observed with BLT1/Di-phos could be due to a decrease in modification of basal phosphorylation sites that depended on LTB 4 -induced phosphorylation events. Eliminating one of the two LTB 4 -induced phosphorylation sites (mutants BLT1/0N/S310 and BLT1/ 0N/T308) resulted in an increase in partial phosphorylations upon stepwise stimulation (Fig. 5C ), supporting the requirement of LTB 4 -induced phosphorylation for further phosphorylation at basal sites. Because the phosphorylation of Ser 310 occurred at a lower LTB 4 concentration than did the phosphorylation of Thr 308 (Figs. 2F and 5C), we propose a model for the sequential phosphorylation of human BLT1 (Fig. 5D ). Because BLT1 is exposed to a gradual increase in LTB 4 concentration during the migration of neutrophils, the extent of phosphorylation may increase in parallel with these physiological changes in LTB 4 .
Activation of G i is required for LTB 4 -induced phosphorylation
We examined the functional significance of LTB 4 -induced stepwise phosphorylation of human BLT1 in HeLa cells. First, surface trafficking similar to that of BLT1/0N was confirmed for each of three mutants, BLT1/0NDb-phos, BLT1/0NDi-phos, and BLT1/0NDphos, indicating that these mutations did not affect the surface trafficking of BLT1 ( fig. S5A) . Previously, several reports demonstrated that GPCRdependent chemotaxis by polymorphonuclear (PMN) leukocytes requires both ERK1/2 and the phosphoinositide 3-kinase (PI3K)-protein kinase B (also called AKT) pathways to facilitate proper cell polarity and motility (16, (30) (31) (32) (33) (34) (35) (36) . On the other hand, an intracellular [Ca 2+ ] increase and the PI3K-AKT pathway are required for PMN leukocyte degranulation (16, (30) (31) (32) (33) (34) (35) (36) , but signaling through mitogen-activated protein kinases (MAPKs) such as ERK1/2 is not ( fig. S5B) (37) . Because the activation of G i by BLT1 is a prerequisite for the initiation of both motility and degranulation, we assessed the importance of G i activation with respect to BLT1 phosphorylation. Pretreatment with PTX, which prevents G i proteins from being activated by GPCRs, before stepwise LTB 4 stimulation substantially reduced ligand-induced phosphorylation of BLT1, suggesting that the activation of G i is required for these phosphorylations ( fig. S5C ).
[Ca 2+ ] increase is a prerequisite for LTB 4 ] response. The BLT1/0N/DE mutant, in which all phosphorylation sites are replaced with Asp or Glu, was also used to simulate the fully phosphorylated form (38) . The finding that BLT1/ 0N/DE requires higher doses of ligand to obtain a response similar to that of BLT1/0N may be due to the reduced affinity for LTB 4 (17) . , which, in turn, promotes further phosphorylation events at basal sites in the C-terminal region.
BLT1/0NDphos exhibited impaired chemotaxis at 100 nM LTB 4 (Fig. 6, A and B) but exhibited no impairment of chemokinesis at this concentration of LTB 4 compared to cells expressing BLT1/0N (Fig. 6B) . Real-time monitoring of cell migration using TAXIScan-FL revealed that 100 nM LTB 4 significantly reduced the migration directionality, but increased the migration velocity, of cells expressing hBLT1/0NDphos compared to cells expressing hBLT1/0N (Fig. 6C) . Because BLT1/0N/DE-expressing cells showed a chemotactic activity similar to that of cells expressing BLT1/0N (Fig. 6, A and C) , the aberrant chemotaxis of BLT1/0NDphos at 100 nM LTB 4 could be due to the lack of phosphorylation. Previous reports demonstrated that chemotaxis requires an LTB 4 -elicited intracellular Ca 2+ influx followed by the activation of MAPKs (30, 31) . At 100 nM LTB 4 , cells expressing BLT1/0NDphos exhibited a sustained [Ca 2+ ] increase compared to the transient response of cells expressing BLT1/0N, although the peak Ca 2+ influx was similar (Fig. 6D) . Moreover, sustained activation of ERK1/2 was observed after stimulation with 100 nM LTB 4 in cells expressing BLT1/0NDphos, whereas activation was transient in cells expressing BLT1/0N (Fig. 6E) . Accordingly, we observed increased expression of a MAPK signaling reporter in cells expressing BLT1/0NDphos compared to cells expressing BLT1/0N (Fig. 6F) . In contrast, these cells showed substantially reduced AKT activation after the stepwise addition of 100 nM LTB 4 (Fig. 6G ). This abnormal signaling in cells expressing BLT1/0NDphos at high concentrations of LTB 4 might be related to the aberrant chemotaxis displayed by these cells at high concentrations of LTB 4 .
Phosphorylation defect reduces the release of LTB 4 -induced b-hexosaminidase Previous research has demonstrated that the LTB 4 -BLT1 axis is involved in degranulation of both human PMN leukocytes (39) and RBL-2H3 cells stably expressing BLT1 (16, 40) . The PI3K-AKT pathway (36), but not the MAPK pathway (37), plays a key role in degranulation of PMN leukocytes. Because signaling through BLT1/0NDphos produced an aberrant AKT response to LTB 4 ( Fig. 6G) , we next investigated whether the phosphorylation deficiency in this mutant form of BLT1 affected the LTB 4 -induced release of b-hexosaminidase, a mast cell lysosomal enzyme that is released upon degranulation, in RBL-2H3 cells. First, we assessed the effect of the AKT inhibitor MK-2206 on the release of b-hexosaminidase by these cells. The activation of AKT observed during the stepwise addition of LTB 4 was markedly reduced by pretreatment with 5 mM MK-2206, although ERK1/2 activation was not affected (Fig. 7A) . The release of b-hexosaminidase elicited by 100 nM LTB 4 was significantly decreased, indicating that AKT activation was required for LTB 4 -induced degranulation in RBL-2H3 cells (Fig. 7B) . In RBL-2H3 cells expressing BLT1/0N, the release of b-hexosaminidase was significantly increased by the stepwise addition of LTB 4 , from 10 to 100 nM. However, the stepwise addition of LTB 4 did not enhance the release of b-hexosaminidase in the cells expressing BLT1/0NDphos (Fig. 7C) . Consistent with this, in the BLT1/0NDphos-expressing cells, the activation of AKT induced by LTB 4 was impaired (Fig. 7, D and E) , as was also found for CHO-K1 cells overexpressing human BLT1/0NDphos (Fig. 6G) . Together, these data demonstrate that the phosphorylation of BLT1 is pivotal for the promotion of PI3K-AKT signaling, leading to b-hexosaminidase release in RBL-2H3 cells.
Lack of phosphorylation impairs the function of wild-type BLT1
We generated various mutant forms of the prospective N-glycosylationdeficient receptor BLT1/0N ( fig. S1A ) and performed functional studies using these mutants, demonstrating aberrant migration and impaired enzyme release resulting from the lack of BLT1 phosphorylation. To eliminate issues regarding surface trafficking, stability, and ligand affinity when using the glycosylation-deficient BLT1s, we further carried out similar functional experiments using human wild-type BLT1 (BLT1/WT and BLT1/WTDphos), in which the glycosylation sites were intact. There was no difference in the surface trafficking or stability between BLT1/WT and BLT1/WTDphos ( fig. S8, A ] response in cells expressing BLT1/WTDphos was slightly sustained at 100 nM, similar to the nonglycosylated mutant ( fig. S8C ). In contrast, we found significant reductions in chemotaxis and b-hexosaminidase release in BLT1/WTDphos elicited by 100 nM LTB 4 (fig. S8, D and E). All these data are consistent with those from experiments using glycosylation-deficient receptors, indicating that the results are not specific to glycosylation-deficient receptors and supporting the biological importance of phosphorylation in native glycosylated forms of the protein.
Phosphorylation is necessary for the low-affinity conformation Previously, Okuno et al. indicated that human BLT1 changes conformation from a high-affinity to low-affinity form after the activation of coupled G proteins. Because BLT1s harboring a mutated helix 8, BLT1/DH8 and BLT1/LLAA ( fig. S9A ), show increased [ 3 H]LTB 4 binding compared to wild-type BLT1, this region is likely to be important for the conformational change to the low-affinity state (25, 41) . Here, we obtained evidence supporting the notion that the disruption of helix 8 leads to defective BLT1 phosphorylation (fig. S9B) ; thus, we propose the involvement of phosphorylation in the conformational change. Moreover, phosphorylation was necessary for the expression of a reporter gene that is activated by the low-affinity conformation ( fig. S10A ) and for the shedding of transforming growth factor-a (TGFa), which requires high concentrations of [LTB 4 ] ( fig. S10B ) (42) . In agreement with the prediction that phosphorylation is required for BLT1 to undergo the conformational change from the highto low-affinity state, we found that BLT1/WT/DE required a high dose of LTB 4 for its activation, compared to wild-type, indicating that it was in a low-affinity conformation. In contrast, BLT1/WTDphos showed hyperactivity, indicating the high-affinity form, in both the reporter assay and the TGFa shedding assay. Collectively, these data support our hypothesis that primary BLT1 phosphorylation is essential for the high-to-low affinity conformational change (Fig. 8) .
We could not rule out the possibility that a distinct signaling pathway through the phosphorylated form is triggered by a high dose of LTB 4 . The phosphorylation may play a role in triggering the recruitment of effectors, such as b-arrestins. Here, we found the reduced binding of b-arrestins, b-arrestin-1 and b-arrestin-2, to LTB 4 -stimulated BLT1/ WTDphos, although substantial amounts of b-arrestins remained bound ( fig. S11 ). These results are consistent with previous findings regarding the phosphorylation-independent recruitment of b-arrestin being essential for the internalization of BLT1 (17) .
DISCUSSION
It has been demonstrated that the distinct GPCR phosphorylation profiles that result from the actions of different kinases are responsible for various signaling outcomes. This concept is known as the "phosphorylation barcode" and is critical for the multidimensional features of GPCR signaling (3-6, 43-45). Thus, the precise analysis of BLT1 phosphorylation is important to clarify the biological functions of this receptor. Many studies have attempted to understand the potential roles of BLT1 phosphorylation (17) (18) (19) ; however, a comprehensive analysis of these phosphorylations is still lacking. Here, we aimed to more extensively characterize the mapping, dynamics, and biological importance of BLT1 phosphorylation events by using Phos-tag technology in combination with site-directed mutagenesis. Although this approach does not provide direct evidence for the phosphorylation of specific sites, as would be revealed by mass spectrometry, it identifies the precise phosphorylation sites involved (46) (47) (48) . Here, we determined the precise sites of basal and LTB 4 -induced phosphorylations in human BLT1. Furthermore, we demonstrated hierarchical and sequential phosphorylation of BLT1 in response to increasing concentrations of LTB 4 . This work demonstrates that Phos-tag SDS-PAGE analysis can be used to assess GPCR phosphorylation and may be useful for research on other GPCRs.
Here, we demonstrate that the lack of BLT1 phosphorylation leads to aberrant neutrophil migration and impaired enzyme release (Fig. 9A) . It was reported that RBL-2H3 cells overexpressing a human BLT1-Ala mutant, in which all the Ser and Thr residues in the C terminus were replaced with Ala, responded to various concentrations of LTB 4 similarly to cells overexpressing the wild-type receptor in a chemotaxis assay (17) . There are no clear explanations for this discrepancy; however, the specific cell lines, mutated residues, and the experimental conditions (96-well versus 48-well chambers) could account for these differences. Previous reports demonstrated the importance of the ligand-elicited intracellular Ca 2+ influx followed by the activation of ERK1/2 in BLT1-stimulated chemotaxis (30, 31) . For example, Ichiki et al. found that lack of the receptor for advanced glycation end products (RAGE) caused attenuation of the BLT1-dependent activation of ERK1/2, leading to reduced velocity of neutrophil motility, although the directionality of migration was slightly enhanced 
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Gi (GDP) P P P P P P P P P P P P P P (i) (ii) (iii) (iv) (49). In contrast, we observed a sustained increase in ERK1/2 activity in cells expressing BLT1/0NDphos after stimulation with 100 nM LTB 4 , resulting in the opposite behavior-a decline in directionality and increased velocity. These findings highlight the importance of ERK1/2 signaling for proper cell motility. There is evidence suggesting that cell polarity in neutrophil chemotaxis is controlled by phosphatidylinositol 3,4,5-trisphosphate [PtdIns(3,4,5)P 3 ] (32-35, 50). Nishio et al. demonstrated that during the initiation of chemotaxis, neutrophils become partially polarized without PtdIns(3,4,5)P 3 and are able to migrate with correct directionality. Thereafter, PI3Kg, phosphatase and tensin homolog (PTEN), and Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) cooperatively localize PtdIns(3,4,5)P 3 to the prospective leading edge. This process leads to the assembly of the leading edge and full polarization, which are critical for proper directionality (32) . Here, the impaired directionality of the cells expressing BLT1/0NDphos in chemotaxis could be due to the reduced production of PtdIns(3,4,5)P 3 , resulting in loss of PtdIns(3,4,5)P 3 accumulation at the leading edge (Fig. 9B) . The aberrant chemotaxis could also be explained by the reduced desensitization of the [Ca 2+ ] increase and ERK1/2 activation. These impairments may directly or indirectly affect the PI3K-AKT pathway. Further studies with phosphorylationdeficient BLT1, which is hyperactive, as well as the phosphomimic form, are likely to unravel the molecular mechanism(s) underlying these events. Together, our results indicate that the abnormal signaling in cells expressing BLT1/0NDphos might be involved in deficient migration at high LTB 4 concentrations.
Furthermore, we found a deficiency of b-hexosaminidase release in cells expressing BLT1/0NDphos. Because b-hexosaminidase release requires a high dose of LTB 4 (ca. >100 nM) (16, 37, 40) , the phenomenon is likely triggered through the low-affinity form of BLT1, harboring increased phosphorylation. In keeping with this idea, a substantial reduction in b-hexosaminidase release was induced by 100 nM LTB 4 in RBL-2H3 cells expressing BLT1/0NDphos. Because the PI3K-AKT pathway, but not the ERK1/2 pathway, plays a key role in the degranulation of PMN leukocytes (36, 37), we suggest that the reduced b-hexosaminidase release could be, at least in part, due to impairment of the PI3K-AKT pathway.
Human BLT1 is highly abundant in phagocytic and immune cells, especially neutrophils (13) , but it is difficult to use human neutrophils for the analysis of BLT1 mutants at present because of the low transfection efficiency. Here, we identified phosphorylation sites in mouse BLT1 and performed functional studies in cultured cells. To provide further support for our conclusions, we hope to generate knock-in mice expressing phosphorylation-deficient forms of BLT1 in our future work to elucidate the in vivo role of BLT1 phosphorylation, similarly to what has been done for other GPCRs (51) . Extensive studies using these mice, such as assessing the effect of the in vivo LTB 4 gradient as found in many disease models in mice, will be required to clarify the regulatory mechanisms of BLT1 involved in chemotaxis and degranulation. Recently, Majumdar et al. reported that the exosomal pool of LTB 4 acts in an autocrine fashion to sensitize neutrophils to the primary chemoattractant and in a paracrine fashion to mediate the recruitment of neighboring neutrophils (52) . To further clarify the relationship between the exosome-mediated LTB 4 relay and phosphorylation-dependent regulation of BLT1 in chemotaxis, these mice will be useful tools in our future works. In addition, to further clarify the involvement of BLT1 phosphorylation in the degranulation in vivo, it is important to discriminate between pathophysiogical degranulation to the extracellular milieu and granule mobilization into the phagocytic lysosomal vacuole. In neutrophils, there are several types of intracellular granules that can be mobilized for releasing their contents into the primary phagocytic vacuole. For example, innate immune phagocytes do not degranulate in response to LTB 4 under physiologic conditions. Because the release of enzymes to the extracellular milieu occurs only under pathophysiologic conditions, it is crucial to distinguish between specific and azurophilic granules in neutrophils and to clarify their mobilization to the primary phagocytic vacuole in response to LTB 4 . Although it is challenging to introduce the various BLT1 mutants into human phagocytic cells, the BLT1 phosphorylation-deficient knock-in mice will be ideal tools to address these issues.
Antibodies that are able to recognize specific phosphorylated forms of BLT1 would be useful tools for elucidating the spatial and temporal dynamics of individual phosphorylation events as well 
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L o w H ig h Chemotaxis P P P P P P P P P P P P P Fig. 9 . Essential roles of BLT1 phosphorylation. (A) Highly phosphorylated BLT1 is important for the precise directionality of chemotaxis and degranulation at higher LTB 4 concentrations. The absence of these phosphorylations results in aberrant migration and impaired enzyme release. (B) Schematic representation of the proposed model for PtdIns(3,4,5)P 3 -dependent polarization in the chemotaxis of neutrophils. During the initiation of chemotaxis, neutrophils become partially polarized without PtdIns(3,4,5)P 3 and are able to migrate with correct directionality. Thereafter, PI3Kg, PTEN, and SHIP1 cooperatively localize PtdIns(3,4,5)P 3 to the prospective leading edge. This process leads to the assembly of the leading edge and full polarization, both of which are critical for proper directionality. The impaired directionality of cells expressing phosphorylation-deficient BLT1 could be due to the reduced production of PtdIns(3,4,5)P 3 , resulting in the loss of PtdIns(3,4,5)P 3 accumulation at the leading edge where LTB 4 concentrations are greatest.
as to identify the kinases involved. The generation of a panel of phosphorylation site-specific antibodies would enable the study of this modification in situ, allowing insights into dynamic protein phosphorylations in the spatially complex structure of cells (53) . Such antibodies would also be useful for identifying the kinases responsible for these modifications, which is also critical for understanding the biological importance of BLT1 phosphorylation.
In 1984, Goldman and Goetzl revealed the existence of high-affinity (K d = 0.36 nM) and low-affinity (K d = 76 nM) forms of a putative LTB 4 receptor in human PMN leukocytes (39) . They further demonstrated that PMN leukocytes, which were deactivated by 10 nM LTB 4 , selectively lost the high-affinity binding sites although low-affinity binding sites remained. Hence, the PMN leukocytes pretreated with 10 nM LTB 4 exhibited a substantially diminished chemotactic response to subsequent LTB 4 stimulation, whereas b-hexosaminidase release was still observed when elicited by higher LTB 4 (300 nM). The findings of the current study show that the loss of high LTB 4 affinity after pretreatment with LTB 4 is likely due to the phosphorylation of BLT1, followed by a conformational change to a low-affinity state. The remaining low-affinity form acts as a LTB 4 sensor and serves to release b-hexosaminidase once the receptor is exposed to a higher dose of LTB 4 .
During the migration of neutrophils, the concentration of LTB 4 to which BLT1 is exposed gradually increases as the cells migrate toward the source. In other words, the degree of BLT1 phosphorylation can be enhanced in parallel with the concentration of LTB 4 such that the graded increase in the phosphorylation of BLT1 acts as a LTB 4 sensor. BLT1 is not phosphorylated and in the high-affinity conformation when the cell encounters low concentrations of LTB 4 , which trigger cell migration. As neutrophils migrate toward the source, BLT1 becomes progressively more phosphorylated and switches to the low-affinity conformation. When BLT1 is exposed to a concentration of LTB 4 high enough to activate the low-affinity form, it triggers other cell responses, such as degranulation. Although more extensive studies are needed to better understand the functional significance of BLT1 modifications, we suggest that basal and LTB 4 -induced phosphorylations are indispensable for BLT1 maturation during cell migration to potentiate degranulation at inflammatory loci. Construction of mutant human BLT1 expression plasmids N-terminally HA-BLT1 was prepared as described previously (25) . The BLT1 mutants were constructed by overlap extension polymerase chain reaction (PCR) using HA-BLT1 as a template (54) . The amplified PCR products digested with Bam HI and Eco RI were subcloned into the pcDNA3 vector, and the sequences were confirmed. The primer sets used are listed in table S1. 
MATERIALS AND METHODS

Materials
Cell culture and transfection
Stable expression of BLT1
HeLa cells, CHO-K1 cells, and RBL-2H3 cells stably expressing wildtype or mutant receptors were established as follows. These cells were transfected with the HA-tagged receptor-expression plasmid. Stable transfectants were selected with geneticin (1 mg/ml) for 20 days. The existence of the HA epitope on the cell surface was confirmed by flow cytometry. After labeling the drug-resistant cells with PE using antibody recognizing HA tag (clone 3F10) and PE-conjugated antibody recognizing rat IgG, a group of HA-positive cells was sorted using MACS Cell Separation Columns and Anti-PE MicroBeads (Miltenyi Biotec).
Flow cytometry
For staining, cells were incubated with the antibody recognizing the HA tag (clone 3F10) in phosphate-buffered saline (PBS) containing 2% goat serum at room temperature for 30 min, followed by staining with PE-conjugated antibody recognizing rat IgG at room temperature for 30 min. The EPICS XL (Beckman Coulter) was used for flow cytometry. To investigate the desensitization and shutdown of intracellular Ca 2+ responses, cells were loaded with 3 mM Fura-2 AM (Dojindo) in a modified Hepes-Tyrode's BSA buffer [25 mM Hepes-NaOH (pH 7.4), 140 mM NaCl, 2.7 mM KCl, 1.0 mM CaCl 2 , 12 mM NaHCO 3 , 5.6 mM D-glucose, 0.37 mM NaH 2 PO 4 , 0.49 mM MgCl 2 , 0.1% (w/v) BSA] containing 0.01% pluronic acid (Molecular Probes) at 37°C for 1 hour. The cells were washed and resuspended in Hepes-Tyrode's BSA buffer at a density of 1 × 10 6 cells/ml. The cell suspension (0.5 ml) was applied to a CAF-100 system (JASCO Corp.), and 5 ml
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of ligand solution was added. The ligands were dissolved in HepesTyrode's BSA buffer after evaporation of the stock solution in ethanol under a nitrogen stream and used immediately. The intracellular Ca . Subsequently, the cells were sonicated for 20 min using a Bioruptor (Cosmo Bio) and centrifuged at 9000g for 10 min at 4°C to remove cellular debris. The resulting supernatant was ultracentrifuged at 100,000g for 1 hour at 4°C. The microsome pellet was resuspended in a buffer containing the abovementioned Hepes buffer. The samples were then subjected to SDS-PAGE or Phos-tag SDS-PAGE as cell membrane fractions.
Phos-tag SDS-PAGE and immunoblotting
For Western blot analyses, protein samples were separated on SDS-PAGE gels and transferred to a nitrocellulose membrane. To detect the band shift that represents phosphorylated proteins, an SDS-PAGE gel containing 50 mM Phos-tag acrylamide with 200 mM MnCl 2 was used. After a blocking step using 1% skimmed milk in TBS-T [20 mM tris-buffered saline (pH 7.4) and 0.1% Tween 20] , blots were probed with the primary antibody [antibody against HA tag (3F10) or antibody recognizing human BLT1] for 1 hour. The membrane was washed with TBS-T and incubated with horseradish peroxidaseconjugated antibody against rat (for 3F10) or mouse (for human BLT1 antibody) IgG for 30 min. The signal was visualized using an enhanced chemiluminescence Western blotting detection system (Nacalai Tesque).
Endoglycosidase treatment
Protein samples containing BLT1 were obtained from the cell membrane fractions described above. Samples were treated with 1 U of PNGase-F in 50 ml of buffer [139.2 mM Na 2 HPO 4 , 40.8 mM NaH 2 PO 4 , 0.4% SDS, 20 mM EDTA, 2% 2-mercaptoethanol] for 16 hours at 4°C. The resultant samples were suspended in a sampling buffer [25 mM tris-HCl (pH 6.5), 5% glycerol, 1% SDS, 0.05% bromophenol blue] and subjected to Western blot analyses.
AP treatment
Protein samples containing wild-type and mutant BLT1 were obtained from the microsome pellet described above without sodium orthovanadate. Samples were suspended in buffer [25 mM HepesNaOH (pH 7.4), 10 mM MgCl 2 , 0.3 M sucrose, and cOmplete protease inhibitor cocktail]. The samples were then treated with 60 U of CIAP (Takara Bio) in 50 ml of AP buffer [50 mM tris-HCl (pH 9.0) and 1 mM MgCl 2 ] for 1 hour at 37°C.
Construction of SrtA-HA-tagged BLT1 expression plasmids The linearized vector was prepared by PCR using two primers (pMK-HA, forward and reverse) derived from pMK-SrtA-HA-G2A-IRES-puro that encodes the LPETGGGGG(SrtA)-HA-tagged G2 accumulation (G2A) receptor and an internal ribosomal entry site (IRES)-puromycin cassette (27) . BLT1/0N and BLT1/0NDphos were amplified by PCR using two primers (BLT1/0N, forward and reverse), respectively. Then, the linearized vector and the insert were fused using the In-Fusion HD enzyme (Clontech), generating pMK-SrtA-HA-BLT1/0N-IRES-puro and pMK-SrtA-HA-BLT1/0NDphos. The constructs were confirmed by sequencing.
Analysis of AF488-labeled BLT1 trafficking
The cytosol of the Ba/F3 cells expressing SrtA-HA-BLT1/0N and SrtA-HA-BLT1/0NDphos were stained with CytoRed and ViVidFluor Cell Blue CMAC, respectively. These cells were mixed the same population, immobilized on a biocompatible anchor for membranecollagen-coated glass base dish (Matsunami) (55) and preincubated in RPMI 1640 (0.1% BSA) for 1 hour at 37°C, 5% CO 2 . SrtA-mediated labeling of BLT1 was carried out as follows (27) . The medium was replaced with RPMI 1640 (0.1% BSA, 30 mM SrtA, 1 mM Gly 3 ) followed by incubation for 1 hour at 37°C, 5% CO 2 . After washing the cells with RPMI 1640 (0.1% BSA) to remove excess Gly 3 , the cells were incubated for labeling BLT1 with AF488 in RPMI 1640 (0.1% BSA, 15 mM AF488-DLPETGG, 30 mM SrtA) for 1 hour at 37°C, 5% CO 2 . The cells were washed twice with RPMI 1640 (0.1% BSA), and then RPMI 1640 (0.1% BSA) was added at 1 ml per dish for confocal microscopy observation. The single-cell analysis of AF488-labeled BLT1/0N and BLT1/0NDphos was simultaneously performed in RPMI 1640 (0.1% BSA). Time-lapse images of AF488-labeled BLT1/0N and BLT1/ 0NDphos were acquired using an LSM 510 confocal microscope equipped with an incubation system to maintain 37°C. Immediately after the addition of LTB 4 (10 nM final concentration), the time-lapse image was acquired for 20 min at 1-min intervals. The acquired images were automatically analyzed using OpenCV.
Chemotaxis assay
Polycarbonate filters with an 8-mm pore size (Neuro Probe) were coated with fibronectin (13.3 mg/ml) (Sigma-Aldrich Corporation) in PBS for 60 min. A dry coated filter was placed on a 96-well blind chamber (Neuro Probe) containing LTB 4 . After incubation at 37°C in 5% CO 2 for 3 hours, the filter was disassembled. The cells on the filter were fixed with methanol and stained with a Diff-Quick staining kit (International Reagent). The upper side of the filter was then scraped free of cells. The number of cells that migrated to the lower side was determined by measuring the OD 595 using a 96-well microplate reader.
To evaluate motility during chemotaxis, CHO-K1 cells expressing wild-type and mutant BLT1/0N were allowed to migrate in the chamber of a TAXIScan-FL optical assay device (Effector Cell Institute), along with the LTB 4 gradient (0 to 100 nM). Phase-contrast images of migrating cells were acquired at 10-s intervals over 15 min. Images were imported as stacks to ImageJ (National Institutes of Health). Velocity and directionality were calculated with manual tracking using the chemotaxis and migration tools in the ImageJ program.
Reporter gene assay HeLa cells were plated in a 24-well plate (1 × 10 5 cells per well) and transfected with 0.8 mg per well of plasmid DNA using Lipofectamine 2000 (Invitrogen). The ratio of transfected plasmid DNA was kept constant at 17:17:1 for SRE-firefly luciferase-pGL4.33 (Promega): BLT1/0N-pcDNA3 or BLT1/0NDphos-pcDNA3:CMV promoterdriven Renilla luciferase (Promega) (56) . The cells were starved for 15 hours and stimulated with 100 nM LTB 4 for 6 hours. The luciferase assay was performed using the Dual-Luciferase Reporter Assay System (Promega) and the MiniLumat LB 9506 luminometer (Berthold). SRE-luc activity was normalized to the Renilla luciferase activity.
For the analyses of BLT1/WT, BLT1/WTDphos, and BLT1/WT/ DE, human embryonic kidney (HEK) 293T cells were plated in a 24-well plate (1 × 10 5 cells per well) and transfected with 0.8 mg per well of plasmid DNA using Lipofectamine 2000 (Invitrogen). The ratio of transfected plasmid DNA was kept constant at 17:17:1 for SRE-NanoLuc luciferase-pNL(NLucP/SRF/Hygro; Promega):BLT1-pcDNA3:phosphoglycerate kinase (PGK)-firefly luciferase-pGL4.53 (luc2/PGK; Promega). The cells were starved for 15 hours and stimulated with 10 or 100 nM LTB 4 for 6 hours. The luciferase assay was performed using the Nano-Glo Dual-Luciferase Reporter Assay System (Promega) and the GloMax 20/20 luminometer (Promega). SRENanoLuc activity was normalized to the levels of firefly luciferase activity.
b-Hexosaminidase release assay Degranulation was determined by measuring the release of a granule marker, b-hexosaminidase, as described previously (16) . The cells were seeded in 24-well collagen-coated plates at 5 × 10 5 cells in 1 ml of medium and were serum-starved for 12 hours. Adherent cells were washed twice in prewarmed PBS. Cells were then treated with LTB 4 (10 nM for 40 min, or 10 nM for 20 min followed by 100 nM for 20 min), and the activity of b-hexosaminidase was quantified in the supernatant and the cell lysates by spectrophotometric analysis using p-nitrophenyl-N-acetyl-b-D-glucosaminide as a substrate (57) . Values for b-hexosaminidase release in the medium were expressed as the percentage of the total b-hexosaminidase, determined from cells lysed in 0.1% Triton X-100. In these experiments, calcium ionophore A23187 (5 mM) was used as a positive-control stimulus to observe the release of b-hexosaminidase.
Pulldown of biotin-labeled HA-BLT1 HeLa cells were plated in a 60-mm dish (1 × 10 6 cells per dish) and transfected with 6 mg of HA-BLT1/WT or HA-BLT1/WTDphos using Lipofectamine 2000 (Invitrogen). After 24 hours, the cells were washed once with PBS and then incubated in 3 ml of PBS containing 0.5 M EZ-Link Sulfo-NHS-SS-Biotin (Thermo Fisher Scientific) for 30 min at 4°C. After washing with PBS, the cells were incubated in a culture medium and stimulated with 10 nM LTB 4 for 30 min at 37°C. Then, the cells were lysed in 500 ml of lysis buffer [50 mM tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, and supplemented with cOmplete protease inhibitor cocktail] and incubated for 30 min at 4°C with gentle mixing, and the lysates were centrifuged for 10 min at 10,000g. The supernatant was transferred into another tube. Streptavidin Agarose Resin suspension (100 ml) (2× diluted with lysis buffer; Thermo Fisher Scientific) was added to the supernatant and gently mixed for 2 hours at room temperature. The Streptavidin Agarose Resin was collected by centrifugation (10,000g, 1 min), washed twice with Wash Buffer 1 [50 mM tris-HCl (pH 7.5), 500 mM NaCl, 0.1% NP-40, 0.05% sodium deoxycholate], followed by Wash Buffer 2 [50 mM tris-HCl (pH 7.5), 0.1% NP-40, 0.05% sodium deoxycholate]. Next, the biotin-labeled proteins were eluted with 100 ml of 2× SDS sample buffer. The samples were subjected to SDS-PAGE followed by Western blot analyses using an antibody against HA tag (clone 3F10).
TGFa shedding assay
The TGFa shedding assay was carried out as previously described (42) . In brief, HEK293T cells were seeded in 12-well plates (2 × 10 5 cells per well), 24 hours before transfection. The cells were transfected with plasmids encoding AP-TGFa (a gift from S. Higashiyama, Ehime University Proteo-Science Center) (0.25 mg per well), HA-BLT1/ WT, HA-BLT1/WTDphos or HA-BLT1/WT/DE (0.1 mg per well), and Ga q/i1 (0.05 mg per well). After 24 hours, the cells were collected and washed with PBS and then suspended in HBSS containing 5 mM Hepes (pH 7.4). The cell suspension was plated in a 96-well plate (80 ml per well) and stimulated with 20 ml of HBSS containing LTB 4 (10 to 150 nM) for 1 hour at 37°C. The 96-well plates were centrifuged for 2 min at 200g, and 80 ml of the supernatant was transferred into another 96-well plate. An 80-ml portion of 2× p-nitrophenyl phosphate disodium salt hexahydrate (pNPP) buffer [10 mM pNPP in 40 mM tris-HCl (pH 9.5), 40 mM NaCl, and 10 mM MgCl 2 ] was added to both the supernatant and the cells. The absorbance at 405 nm (A 405 ) of both plates was read before and after a 1-hour incubation at 37°C using a microplate reader (Thermo Fisher Scientific). AP-TGFa release was calculated by the following formulae:
AP -TGFa in supernatant ð%Þ ¼ ðDOD 405 Sup=½DOD 405 Sup þ DOD 405 CellÞ Â 100 AP -TGFa release ð%Þ ¼ AP-TGFa in supernatant under a stimulated condition ð%Þ À AP -TGFa in supernatant under a vehicle -treated condition ð%Þ NanoBiT-b-arrestin recruitment assay For the NanoBiT-b-arrestin recruitment assay (58), a receptor construct was designed to fuse the small fragment (SmBiT) of the NanoBiT complementation luciferase to the C terminus of HA-BLT1 with a 15-amino acid flexible linker (GGSGGGGSGGSSSGG), whose sequences were recommended by the manufacturer (Promega). The construct (HA-BLT1-SmBiT) was assembled and inserted into a pCAGGS mammalian expression plasmid (a gift from J.-i. Miyazaki, Osaka University) using an NEBuilder HiFi DNA Assembly system (New England Biolabs). A b-arrestin construct was generated by fusing the large fragment (LgBiT), whose nucleotide sequences were gene-synthesized with mammalian codon optimization (GenScript), to the N terminus of human b-arrestin1 or b-arrestin2 (barr1 or barr2, respectively) with the 15-amino acid linker. The LgBiT-barr1 and LgBiT-barr2 were inserted into the pCAGGS plasmid. HEK293A cells (Thermo Fisher Scientific) were seeded in a 10-cm dish at 2 × 10 6 cells in 10 ml of DMEM, supplemented with 10% FBS and penicillin (100 U/ml) and streptomycin (100 mg/ml), and cultured for 1 day. The cells were transfected with a mixture of HA-BLT1-SmBiT plasmid (1 mg) and the LgBiT-barr plasmid (LgBiT-barr1 or LgBiT-barr2; 500 ng) by diluting in 500 ml of Opti-MEM I Reduced Serum Medium (Thermo Fisher Scientific) and combining 25 ml of polyethylenimine reagent (1 mg/ml) [Polyethylenimine "Max" (molecular weight 40,000), Polysciences] diluted in 500 ml of the Opti-MEM. As a negative control, the pCAGGS plasmid was used. Twenty-four hours after the addition of the transfection solution, the cells were harvested with 5 ml of a 0.53 mM EDTAcontaining Dulbecco's phosphate-buffered saline (D-PBS), followed by rinsing with 5 ml of HBSS containing 5 mM Hepes (pH 7.4). The cells were centrifuged at 190g for 5 min and suspended in 10 ml of 0.01% BSA (fatty acid-free grade; SERVA)-containing HBSS. The cell suspension was seeded in a 96-well white plate at a volume of 80 ml per well and loaded with 20 ml of 50 mM coelenterazine (Carbosynth) diluted in the BSA-HBSS. After incubation at room temperature for 2 hours, background luminescent signals were measured using the luminescent microplate reader SpectraMax L equipped with two detectors (Molecular Devices). Prediluted LTB 4 solution (20 ml at final concentrations of 100 pM to 100 nM, 3.2-fold dilution) or vehicle was manually added to the cells. After ligand addition (5 min), luminescent signals were measured for 5 min with 20-s intervals. For each well, the luminescent signal was normalized to the initial count and fold change values over 5 to 10 min after ligand stimulation was averaged. The fold change barr recruitment signals were fitted to a fourparameter sigmoidal concentration-response curve, and EC 50 (median effective concentration) values were obtained, using the Prism 7 software (GraphPad Prism).
Statistical analysis
For each experiment, at least three independent experiments were performed. The images obtained from one representative experiment were presented. To determine statistical significance, values were compared by Student's t test, one-way or two-way ANOVA with Tukey post hoc test, Bonferroni post hoc test, or Kruskal-Wallis test with Dunn's post hoc test using Prism 7 software. The differences were considered significant if P values were less than 0.05.
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